[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol → HCID 67974777, compound
Reaction equation
Cl[C:2]1[CH:11]=[C:10]2[C:5]([CH:6]=[C:7]([NH:12][C:13]([CH:15]3[CH2:17][CH2:16]3)=[O:14])[N:8]=[CH:9]2)=[CH:4][N:3]=1.CC1(C)C(C)(C)OB([C:26]2[CH:27]=[C:28]([CH2:32][OH:33])[CH:29]=[CH:30][CH:31]=2)O1>>[OH:33][CH2:32][C:28]1[CH:27]=[C:26]([C:2]2[CH:11]=[C:10]3[C:5]([CH:6]=[C:7]([NH:12][C:13]([CH:15]4[CH2:17][CH2:16]4)=[O:14])[N:8]=[CH:9]3)=[CH:4][N:3]=2)[CH:31]=[CH:30][CH:29]=1Participants
3
Procedure
The title compound was prepared following a procedure similar to example 162 using N-(7-chloro-2,6-naphthyridin-3-yl)cyclopropanecarboxamide and (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol.
Sources & evidence
- ORD record
- ord-b3fc4ac76ea84677b10136a67f64e61a
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09206175B2
Reaction notes
Loading…